
Office of Communications
and Public Liaison (OCPL)
Building 31, Room 5C27
31 Center Drive, MSC 2292
Bethesda, MD 20892
Phone: 301-496-1752
nianews3@mail.nih.gov
(Published in LINKS: Minority Research & Training - Fall 2010) Poverty may predict chronic kidney disease (CKD) in African Americans but not whites according to a study recently conducted by investigators at the NIA, Johns Hopkins...
(Published in LINKS: Minority Research & Training - Fall 2010) Some people remember their high school prom as the perfect party to celebrate the end of an era. Others do not fondly recall their evening. For older adults living in or...
(Published in LINKS: Minority Research & Training - Fall 2010) Poverty may predict chronic kidney disease (CKD) in African Americans but not whites according to a study recently conducted by investigators at the NIA, Johns Hopkins...
African-American family members and other informants are less likely than are their white counterparts to report mild cognitive impairment in people who are cognitively impaired but not demented (CIND), NIA-funded research shows. The...
More rigorous and long-term studies are needed before specific life style measures to prevent Alzheimer's disease and cognitive decline can be recommended, according to an independent panel convened by the National Institutes of Health...
Older adults with strong muscles are at lower risk of developing Alzheimer's disease and mild cognitive impairment than their weaker peers, researchers report in Archives of Neurology. The study builds on previous research showing a...
The cognitive health of older adults with “subjective cognitive impairment” (SCI) declined faster and further than that of people without SCI over a period of years, a recent study found. The study suggests that very early,...
William R. Markesbery, M.D., who for more than 30 years was director of the University of Kentucky (UK) Sanders-Brown Center on Aging, died January 30, 2010, at age 77, in Lexington, KY. Dr. Markesbery led the UK Sanders-Brown Center on...
A recent study examining predictors of participant dropout in a clinical trial of treatments for mild cognitive impairment (MCI) has found that participants recruited by NIA-funded Alzheimer's Disease Centers (ADCs) and university-...
Allopregnanolone, a metabolite of the hormone progesterone that is made in the central nervous system, reversed neurological decline and improved performance on memory tests in 3-month-old mice with characteristics of Alzheimer's...